FDA Approves the First New Type of Schizophrenia Drug in Decades
The U.S. Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) to treat schizophrenia in adults, offering the first new treatment in decades for the psychiatric disorder.e60dc2a1-f33c-4a05-9b50-8e3e8e59762958f19463-a3e1-4a5e-992e-622af04e95d3…